US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

22.43

-0.6750-2.92%

Volume:879.89K

Turnover:19.76M

Market Cap:1.29B

PE:-9.63

High:23.29

Open:23.17

Low:21.86

Close:23.10

Loading ...

Overview Company News Filings

Structure’s obesity pipeline value prop ‘unperturbed,’ says H.C. Wainwright

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Piper Sandler

Structure Therapeutics Price Target Maintained With a $91.00/Share by JMP Securities

Shares of Some Obesity Drug Developers Fall After Merck Signs up to $2 Bln Deal for Oral Obesity Drug

THOMSON REUTERS

Shares of Structure Therapeutics Fall 7.2%, Viking Therapeutics Fall 7.9%

THOMSON REUTERS

BUZZ-Shares of some obesity drug developers fall after Merck signs $2 bln deal to develop oral obesity drug

Buy Rating on Structure Therapeutics: Promising Developments in GPCR’s Oral Amylin-Based Drug and Broad Obesity Treatment Pipeline

BRIEF-Structure Therapeutics Announces Selection Of Lead Oral Small Molecule Amylin Receptor Agonist Accg-2671 For The Treatment Of Obesity

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist Accg-2671 for the Treatment of Obesity

THOMSON REUTERS

Structure Therapeutics Inc - Phase 1 Study of Accg-2671 Expected to Start by Year End 2025

THOMSON REUTERS

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity

Is Structure Therapeutics Inc. (GPCR) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Analysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks

Stock Track | STRUCTURE THERAPEUTICS INC Soars 5.14% on Bullish Analyst Coverage

HC Wainwright Initiates Structure Therapeutics at Buy

MT Newswires Live

Structure Therapeutics Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $80

THOMSON REUTERS

Structure Therapeutics initiated with a Buy at H.C. Wainwright

Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?

Stock Track | Structure Therapeutics Soars 5% on Promising Obesity Drug Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GPCR/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GPCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":22.425,"timestamp":1745345100805,"preClose":23.1,"halted":0,"volume":879888,"delay":0,"floatShares":49653148,"shares":57342847,"eps":-2.327592,"marketStatus":"Trading","change":-0.675,"latestTime":"04-22 14:05:04 EDT","open":23.17,"high":23.29,"low":21.86,"amount":19764742.007184003,"amplitude":0.061905,"askPrice":22.47,"askSize":163,"bidPrice":22.37,"bidSize":223,"shortable":3,"etf":0,"ttmEps":-2.327592,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":23.1,"preHourTrading":{"tag":"盘前","latestPrice":23.9,"preClose":23.1,"latestTime":"09:23 EDT","volume":121,"amount":2887.759864,"timestamp":1745328218841},"postHourTrading":{"tag":"盘后","latestPrice":23.936,"preClose":23.1,"latestTime":"19:54 EDT","volume":55484,"amount":1282134.1633,"timestamp":1745279663039},"volumeRatio":0.577853,"impliedVol":0.8616,"impliedVolPercentile":0.644},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","floatShares":49653148,"roa":"-14.28%","roe":"-18.60%","lyrEps":-2.327592,"volumeRatio":0.577853,"shares":57342847,"dividePrice":0,"high":23.29,"amplitude":0.061905,"preClose":23.1,"low":21.86,"week52Low":13.22,"pbRate":"1.49","week52High":62.74,"institutionHeld":0,"latestPrice":22.425,"committee":0.15544,"eps":-2.327592,"divideRate":0,"volume":879888,"delay":0,"ttmEps":-2.327592,"open":23.17,"prevYearClose":27.12,"prevWeekClose":21.76,"prevMonthClose":17.31,"prevQuarterClose":17.31,"fiveDayClose":18.95,"twentyDayClose":21.05,"sixtyDayClose":28.22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GPCR\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2492743531","title":"Structure’s obesity pipeline value prop ‘unperturbed,’ says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2492743531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492743531?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:40","pubTimestamp":1734619224,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) is expanding its obesity pipeline with ACCG-2671, a once-daily small molecule amylin agonist, setting the stage for a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structures-obesity-pipeline-value-prop-unperturbed-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structures-obesity-pipeline-value-prop-unperturbed-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2492742150","title":"Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2492742150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492742150?lang=en_us&edition=fundamental","pubTime":"2024-12-19 05:55","pubTimestamp":1734558912,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR – Researc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/structure-therapeutics-inc-sponsored-adr-gpcr-gets-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/structure-therapeutics-inc-sponsored-adr-gpcr-gets-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2492826611","title":"Structure Therapeutics Price Target Maintained With a $91.00/Share by JMP Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2492826611","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492826611?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:58","pubTimestamp":1734533880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GPCR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 18, 2024 09:58 ET (14:58 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","JMP","LENZ"],"gpt_icon":0},{"id":"2492827181","title":"Shares of Some Obesity Drug Developers Fall After Merck Signs up to  $2 Bln Deal for Oral Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2492827181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492827181?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:33","pubTimestamp":1734532439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0V0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4599","GPCR","VKTX","BK4007","BK4588","BK4139"],"gpt_icon":0},{"id":"2492181584","title":"Shares of Structure Therapeutics Fall 7.2%, Viking Therapeutics Fall 7.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492181584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492181584?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:33","pubTimestamp":1734532439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0V0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VKTX","BK4007","BK4139","BK4599","GPCR","BK4585","BK4588"],"gpt_icon":0},{"id":"2492618978","title":"BUZZ-Shares of some obesity drug developers fall after Merck signs $2 bln deal to develop oral obesity drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2492618978","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492618978?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:28","pubTimestamp":1734532119,"startTime":"0","endTime":"0","summary":"BUZZ-Shares of some obesity drug developers fall after Merck signs $2 bln deal to develop oral obesity drug** Shares of obesity drug developers Structure Therapeutics GPCR.O and Viking Therapeutics VK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4N3NJ10S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0354030511.USD","LU2491049909.HKD","01638","LU1037948541.HKD","LU0306807586.USD","LU0965508806.USD","BK1555","LU0234572021.USD","LU0820561909.HKD","LU0321505868.SGD","03692","GPCR","LU0203201768.USD","LU1035775433.USD","LU1883839398.USD","LU0417517546.SGD","LU0672654240.SGD","LU0882574055.USD","LU1023059063.AUD","LU1093756168.USD","LU0868494617.USD","SG9999014575.USD","PFE","LU2237443978.SGD","LU2265009873.SGD","LU0238689110.USD","IE00BFTCPJ56.SGD","SG9999014542.SGD","LU2023250843.SGD","LU0097036916.USD","LU2324357040.USD","MRK","LU2237443382.USD","SG9999014567.USD","LU1974910355.USD","SG9999002224.SGD","SG9999018865.SGD","LU0823416689.USD","LU1291159041.SGD","LU0882574139.USD","IE0009355771.USD","LU1093756325.SGD","SGXZ31699556.SGD","VKTX","LU0289739699.SGD","LU0861579265.USD","SG9999015358.SGD","LLY","BK4007","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2492945117","title":"Buy Rating on Structure Therapeutics: Promising Developments in GPCR’s Oral Amylin-Based Drug and Broad Obesity Treatment Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2492945117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492945117?lang=en_us&edition=fundamental","pubTime":"2024-12-18 09:05","pubTimestamp":1734483916,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR –...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-on-structure-therapeutics-promising-developments-in-gpcrs-oral-amylin-based-drug-and-broad-obesity-treatment-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-on-structure-therapeutics-promising-developments-in-gpcrs-oral-amylin-based-drug-and-broad-obesity-treatment-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GPCR"],"gpt_icon":0},{"id":"2492991567","title":"BRIEF-Structure Therapeutics Announces Selection Of Lead Oral Small Molecule Amylin Receptor Agonist Accg-2671 For The Treatment Of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2492991567","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492991567?lang=en_us&edition=fundamental","pubTime":"2024-12-18 05:48","pubTimestamp":1734472097,"startTime":"0","endTime":"0","summary":"BRIEF-Structure Therapeutics Announces Selection Of Lead Oral Small Molecule Amylin Receptor Agonist Accg-2671 For The Treatment Of ObesityDec 17 (Reuters) - Structure Therapeutics Inc GPCR.O:STRUCTUR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUABVQ1MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2492918339","title":"Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist Accg-2671 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2492918339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492918339?lang=en_us&edition=fundamental","pubTime":"2024-12-18 05:01","pubTimestamp":1734469260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUABVQ1MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2492918331","title":"Structure Therapeutics Inc - Phase 1 Study of Accg-2671 Expected to Start by Year End 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2492918331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492918331?lang=en_us&edition=fundamental","pubTime":"2024-12-18 05:01","pubTimestamp":1734469260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUABVQ1MB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"2492918505","title":"Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2492918505","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492918505?lang=en_us&edition=fundamental","pubTime":"2024-12-18 05:01","pubTimestamp":1734469260,"startTime":"0","endTime":"0","summary":"Preclinical studies with ACCG-2671 demonstrate potent target engagement, robust weight loss, favorable safety profile and PK properties supportive of once-daily dosing in humans ACCG-2671 is the most ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/17/2998609/0/en/Structure-Therapeutics-Announces-Selection-of-Lead-Oral-Small-Molecule-Amylin-Receptor-Agonist-ACCG-2671-for-the-Treatment-of-Obesity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","PK","BK4139","BK4181","GPCR","BK4218","BK4599"],"gpt_icon":0},{"id":"2492709643","title":"Is Structure Therapeutics Inc. (GPCR) the Best Weight Loss Stock to Buy Now According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2492709643","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492709643?lang=en_us&edition=fundamental","pubTime":"2024-12-17 02:33","pubTimestamp":1734374030,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds.In this article, we are going to take a look at where Structure Therapeutics Inc.  stands against the other weight loss stocks.The Revolution in Obesity Treatment: Opportunities and Challenges of GLP-1 Medications. Given this increase in demand, Morgan Stanley Research has raised its forecast for the worldwide obesity medication market from $77 billion to $105 billion by 2030. Branded obesity medications brought approximately $6 billion in 2023.By 2030, the GLP-1 market is expected to grow to $100 billion, driven equally by obesity and diabetes, according to JP Morgan Research. Thirty million GLP-1 users, or around 9% of the population, may be in the US by 2030. The rising demand for obesity drugs will have a broad effect, helping industries like biotech but creating challenges for others like the food and beverage industry.Some are praising the most recent generation of GLP-1 pharmaceuticals ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7LmVs0g6tjS3C0TPzkdMZQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e0f93bb3343b5abefc65487e54da3de3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7LmVs0g6tjS3C0TPzkdMZQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e0f93bb3343b5abefc65487e54da3de3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/structure-therapeutics-inc-gpcr-best-183350104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2111349929.HKD","IE00BKVL7J92.USD","BK4127","LU2023251221.USD","LU1989772840.SGD","BK4534","LU1162221912.USD","LU0006306889.USD","LU0158827781.USD","LU2357305700.SGD","BK4581","LU2089284900.SGD","LU0098860793.USD","LU0225283273.USD","BK4516","LU1668664300.SGD","PSQ","MNQmain","TQQQ","LU1548497426.USD","LU0267386448.USD","LU1989772923.USD","SQQQ","BK4599","QLD","BK4585","TSYW.SI","LU0320765646.SGD","LU0971096721.USD","LU1720051017.SGD","BK4588","LU1720051108.HKD","USJW.SI","LU2089283258.USD","LU1074936037.SGD","IE00BZ1G4Q59.USD","LU2271345857.HKD","LU0106261372.USD","GPCR","NVIW.SI","NQmain","LU0158827948.USD","LU1363072403.SGD","USAW.SI","LU0106831901.USD",".IXIC","QID","LU2028103732.USD","BK4504"],"gpt_icon":1},{"id":"2490713287","title":"Analysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490713287","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490713287?lang=en_us&edition=fundamental","pubTime":"2024-12-09 23:30","pubTimestamp":1733758218,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Artelo Biosciences (ARTL – Research Report) and Stru...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artelo-biosciences-artl-and-structure-therapeutics-inc-sponsored-adr-gpcr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artelo-biosciences-artl-and-structure-therapeutics-inc-sponsored-adr-gpcr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTL","HCSG","BK4007","BK4137","BK4599","GPCR"],"gpt_icon":0},{"id":"2489522738","title":"Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2489522738","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489522738?lang=en_us&edition=fundamental","pubTime":"2024-12-08 19:05","pubTimestamp":1733655918,"startTime":"0","endTime":"0","summary":"There’s been something of a sea change in the economic outlook for 2025, in the aftermath of last month’s election. The prospect of a second Trump administration, with his known preference for deregulation and tax cuts, has market watchers expecting a growth-friendly environment.Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks. Desh Peramunetilleke, Jefferies’ Global Head of Quantitative Strategy, notes that reduced regulation, combined with the potential for lower corporate tax rates, could significantly boost the biotech sector, with smaller biotech stocks poised to benefit the most.But Metagenomi isn’t stopping there. Through a partnership with Ionis Pharmaceuticals, the company is integrating RNA-targeted therapeutics with its gene-editing systems. This collaboration focuses on cardiometabolic development programs, initially targeting four conditions, including transthyr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/v2f8RUmuYjv4vuSZGqT1FA--~B/aD01NDM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/fb203f95ffee9f374f54e6aa062b8ef8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/v2f8RUmuYjv4vuSZGqT1FA--~B/aD01NDM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/fb203f95ffee9f374f54e6aa062b8ef8"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jefferies-predicts-1000-surge-2-110518004.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jefferies-predicts-1000-surge-2-110518004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","BK4139","GPCR","BK4007","MGX","AGT"],"gpt_icon":0},{"id":"1190364300","title":"Stock Track | STRUCTURE THERAPEUTICS INC Soars 5.14% on Bullish Analyst Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=1190364300","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190364300?lang=en_us&edition=fundamental","pubTime":"2024-12-04 23:48","pubTimestamp":1733327299,"startTime":"0","endTime":"0","summary":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD  rallied 5.14% in the intraday session on Wednesday, driven by positive analyst coverage from H.C. Wainwright.H.C. Wainwright initiated coverage on GPCR with a Buy rating and an $80 price target. According to analysts polled by FactSet, GPCR has an average Buy rating and a mean price target of $86.73, implying significant upside potential.The bullish analyst calls highlight GPCR's focus on developing oral obesity medications, a promising therape","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | STRUCTURE THERAPEUTICS INC Soars 5.14% on Bullish Analyst Coverage","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GPCR"],"gpt_icon":0},{"id":"2488193209","title":"HC Wainwright Initiates Structure Therapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2488193209","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488193209?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:13","pubTimestamp":1733317989,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) has an average rating of buy and mean price target of $86.73, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4007","BK4139","BK4599","GPCR"],"gpt_icon":0},{"id":"2488694391","title":"Structure Therapeutics Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2488694391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488694391?lang=en_us&edition=fundamental","pubTime":"2024-12-04 19:19","pubTimestamp":1733311199,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N5199:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2488169111","title":"Structure Therapeutics initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2488169111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488169111?lang=en_us&edition=fundamental","pubTime":"2024-12-04 19:10","pubTimestamp":1733310615,"startTime":"0","endTime":"0","summary":"H.C. Wainwright initiated coverage of Structure Therapeutics (GPCR) with a Buy rating and $80 price target Structure’s focus on oral obesity medici...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2486873720","title":"Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2486873720","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486873720?lang=en_us&edition=fundamental","pubTime":"2024-11-27 23:15","pubTimestamp":1732720517,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Up and Coming Stocks To Buy According to Analysts.In this article, we are going to take a look at where Structure Therapeutics Inc.  stands against the other up and coming stocks.Additionally, expectations for M&A activity are on the rise, fueled by renewed investor eagerness. Mitch Berlin, vice chair of strategy and transactions at EY Americas, joined CNBC's 'The Exchange' on November 22 to discuss what he sees for M&A activity in 2025. He noted that while there is a general sense of optimism, it is essential to differentiate between private equity and corporate growth. Berlin anticipates a 16% increa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7LmVs0g6tjS3C0TPzkdMZQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e0f93bb3343b5abefc65487e54da3de3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7LmVs0g6tjS3C0TPzkdMZQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e0f93bb3343b5abefc65487e54da3de3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-structure-therapeutics-inc-gpcr-151517374.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","MNQmain","SQQQ","BK4007","FTC","BK4599","PSQ","QLD","NQmain","GPCR","QID",".IXIC"],"gpt_icon":1},{"id":"1162258308","title":"Stock Track | Structure Therapeutics Soars 5% on Promising Obesity Drug Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1162258308","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162258308?lang=en_us&edition=fundamental","pubTime":"2024-11-22 23:50","pubTimestamp":1732290626,"startTime":"0","endTime":"0","summary":"Shares of Structure Therapeutics Inc.  soared 5.12% in Friday's intraday trading session, as investors cheered the biopharmaceutical company's promising progress with its lead obesity drug candidate.Structure Therapeutics is a clinical-stage company focused on developing innovative oral treatments for chronic metabolic conditions like obesity. Its lead product GSBR-1290 is an oral small molecule targeting the GLP-1 receptor, a proven pathway for potential weight loss and metabolic benefits.Suppo","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Structure Therapeutics Soars 5% on Promising Obesity Drug Progress","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GPCR"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":81,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GPCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"GPCR","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2024-11-13","symbol":"GPCR","fiscalQuarterEnding":"2024/09","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GPCR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GPCR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.6154,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1740888000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GPCR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GPCR","date":"2025-04-21","current":-10.183801,"percent":0.952919,"low":-50.180001,"twenty":-25.313941,"median":-21.002823,"eighty":-16.512979,"high":-6.622278,"avg":-21.690459,"sd":7.849935,"marketCap":1247780350},"quantilePoints":[{"date":"2023-02-03","current":-25.001825,"twenty":-43.272389,"median":-43.272389,"eighty":-32.310051,"marketCap":951294422},{"date":"2023-02-10","current":-22.116999,"twenty":-35.964163,"median":-23.496907,"eighty":-22.21316,"marketCap":841529681},{"date":"2023-02-17","current":-21.285207,"twenty":-24.521021,"median":-22.645883,"eighty":-21.915061,"marketCap":809880847},{"date":"2023-02-24","current":-23.36709,"twenty":-23.715192,"median":-22.645883,"eighty":-21.847749,"marketCap":889094402},{"date":"2023-03-03","current":-25.530709,"twenty":-24.422936,"median":-22.718004,"eighty":-21.972757,"marketCap":971417957},{"date":"2023-03-10","current":-22.636267,"twenty":-24.85566,"median":-22.790125,"eighty":-22.063149,"marketCap":861287334},{"date":"2023-03-17","current":-22.232392,"twenty":-24.422936,"median":-22.70358,"eighty":-22.09392,"marketCap":845920270},{"date":"2023-03-24","current":-21.876596,"twenty":-23.762311,"median":-22.568955,"eighty":-21.891982,"marketCap":832382619},{"date":"2023-03-31","current":-16.960589,"twenty":-23.565181,"median":-22.314128,"eighty":-21.634271,"marketCap":870434396},{"date":"2023-04-06","current":-17.823234,"twenty":-23.376706,"median":-22.232392,"eighty":-21.285207,"marketCap":914706175},{"date":"2023-04-14","current":-17.473898,"twenty":-23.36709,"median":-22.116999,"eighty":-18.643102,"marketCap":896777933},{"date":"2023-04-21","current":-17.210114,"twenty":-23.194,"median":-22.059302,"eighty":-17.623613,"marketCap":883240282},{"date":"2023-04-28","current":-17.815518,"twenty":-23.078607,"median":-21.876596,"eighty":-17.586227,"marketCap":914310203},{"date":"2023-05-05","current":-17.709107,"twenty":-22.982446,"median":-21.689083,"eighty":-17.623613,"marketCap":908849077},{"date":"2023-05-12","current":-17.00755,"twenty":-22.790125,"median":-21.491953,"eighty":-17.586227,"marketCap":956079400},{"date":"2023-05-19","current":-15.32957,"twenty":-22.780509,"median":-20.818827,"eighty":-17.473898,"marketCap":861751761},{"date":"2023-05-26","current":-19.808636,"twenty":-22.761276,"median":-19.808636,"eighty":-17.466769,"marketCap":1113542462},{"date":"2023-06-02","current":-21.830342,"twenty":-22.668962,"median":-20.674586,"eighty":-17.472472,"marketCap":1227192672},{"date":"2023-06-09","current":-23.110075,"twenty":-22.668962,"median":-21.38858,"eighty":-17.563702,"marketCap":1299132872},{"date":"2023-06-16","current":-21.061141,"twenty":-22.668962,"median":-21.491953,"eighty":-17.586212,"marketCap":1183952020},{"date":"2023-06-23","current":-21.782692,"twenty":-22.640113,"median":-21.568882,"eighty":-17.608538,"marketCap":1224514048},{"date":"2023-06-30","current":-27.561913,"twenty":-22.772816,"median":-21.571672,"eighty":-17.623492,"marketCap":1549392931},{"date":"2023-07-07","current":-24.451072,"twenty":-23.059375,"median":-21.612515,"eighty":-17.625039,"marketCap":1374517018},{"date":"2023-07-14","current":-21.428724,"twenty":-23.103781,"median":-21.707815,"eighty":-17.644282,"marketCap":1204615694},{"date":"2023-07-21","current":-23.069233,"twenty":-23.103781,"median":-21.780436,"eighty":-17.700571,"marketCap":1296836908},{"date":"2023-07-28","current":-23.552536,"twenty":-23.333385,"median":-21.782692,"eighty":-17.727736,"marketCap":1324005814},{"date":"2023-08-04","current":-21.592094,"twenty":-23.51737,"median":-21.782692,"eighty":-17.804907,"marketCap":1213799550},{"date":"2023-08-11","current":-19.978813,"twenty":-23.374783,"median":-21.781564,"eighty":-17.817061,"marketCap":1123108978},{"date":"2023-08-18","current":-16.072919,"twenty":-23.333385,"median":-21.735043,"eighty":-17.644282,"marketCap":1053531639},{"date":"2023-08-25","current":-16.66259,"twenty":-23.197654,"median":-21.646551,"eighty":-17.586168,"marketCap":1092182818},{"date":"2023-09-01","current":-16.458249,"twenty":-23.185384,"median":-21.592094,"eighty":-17.468195,"marketCap":1078788845},{"date":"2023-09-08","current":-16.680105,"twenty":-23.150918,"median":-21.568882,"eighty":-17.319402,"marketCap":1093330873},{"date":"2023-09-15","current":-18.326514,"twenty":-23.110075,"median":-21.460338,"eighty":-17.211393,"marketCap":1201248026},{"date":"2023-09-22","current":-19.937893,"twenty":-23.078607,"median":-21.067948,"eighty":-17.309925,"marketCap":1306869070},{"date":"2023-09-29","current":-21.876218,"twenty":-23.069233,"median":-21.012104,"eighty":-17.319402,"marketCap":1433920470},{"date":"2023-10-06","current":-37.165618,"twenty":-23.194,"median":-21.285207,"eighty":-17.395476,"marketCap":2436094784},{"date":"2023-10-13","current":-44.162453,"twenty":-23.552536,"median":-21.525005,"eighty":-17.459473,"marketCap":2894716299},{"date":"2023-10-20","current":-45.222784,"twenty":-23.852048,"median":-21.571672,"eighty":-17.466769,"marketCap":2964217822},{"date":"2023-10-27","current":-47.275909,"twenty":-23.892891,"median":-21.592094,"eighty":-17.469621,"marketCap":3098794020},{"date":"2023-11-03","current":-48.538851,"twenty":-24.328544,"median":-21.646551,"eighty":-17.490333,"marketCap":3181576088},{"date":"2023-11-10","current":-38.273225,"twenty":-24.864943,"median":-21.735043,"eighty":-17.514986,"marketCap":2508695101},{"date":"2023-11-17","current":-27.570058,"twenty":-25.04304,"median":-21.781564,"eighty":-17.543453,"marketCap":2122673903},{"date":"2023-11-24","current":-32.691508,"twenty":-27.365869,"median":-21.782692,"eighty":-17.586168,"marketCap":2516984612},{"date":"2023-12-01","current":-35.337541,"twenty":-28.3175,"median":-21.830342,"eighty":-17.593664,"marketCap":2720707940},{"date":"2023-12-08","current":-37.983573,"twenty":-33.138225,"median":-21.904522,"eighty":-17.623452,"marketCap":2924431267},{"date":"2023-12-15","current":-37.177707,"twenty":-34.105722,"median":-22.049686,"eighty":-17.625039,"marketCap":2862386033},{"date":"2023-12-22","current":-20.939825,"twenty":-34.105722,"median":-22.001606,"eighty":-17.644282,"marketCap":1612198995},{"date":"2023-12-29","current":-23.446258,"twenty":-34.065552,"median":-22.068918,"eighty":-17.684898,"marketCap":1805174329},{"date":"2024-01-05","current":-26.187472,"twenty":-34.000259,"median":-22.102574,"eighty":-17.702705,"marketCap":2016225834},{"date":"2024-01-12","current":-28.789086,"twenty":-33.67371,"median":-22.232392,"eighty":-17.746366,"marketCap":2216529345},{"date":"2024-01-19","current":-27.710368,"twenty":-33.290514,"median":-22.259189,"eighty":-17.804907,"marketCap":2133476670},{"date":"2024-01-26","current":-26.745867,"twenty":-33.138225,"median":-22.283013,"eighty":-17.817061,"marketCap":2059217807},{"date":"2024-02-02","current":-28.598724,"twenty":-32.691508,"median":-22.44298,"eighty":-17.823234,"marketCap":2201872991},{"date":"2024-02-09","current":-29.823387,"twenty":-32.667396,"median":-22.576119,"eighty":-17.835432,"marketCap":2296162205},{"date":"2024-02-16","current":-28.427399,"twenty":-32.293017,"median":-22.636267,"eighty":-17.890184,"marketCap":2188682272},{"date":"2024-02-23","current":-26.035182,"twenty":-31.181303,"median":-22.647193,"eighty":-17.91403,"marketCap":2004500750},{"date":"2024-03-01","current":-25.743294,"twenty":-31.092467,"median":-22.775115,"eighty":-17.959972,"marketCap":1982027673},{"date":"2024-03-08","current":-22.849791,"twenty":-30.933832,"median":-22.849791,"eighty":-18.031985,"marketCap":1759251085},{"date":"2024-03-15","current":-18.291889,"twenty":-29.823387,"median":-22.775115,"eighty":-18.031985,"marketCap":1639319082},{"date":"2024-03-22","current":-22.815466,"twenty":-29.601298,"median":-22.761276,"eighty":-18.070517,"marketCap":2044722039},{"date":"2024-03-28","current":-22.311113,"twenty":-29.398245,"median":-22.645883,"eighty":-18.070517,"marketCap":1999521939},{"date":"2024-04-05","current":-20.434088,"twenty":-29.301795,"median":-22.601624,"eighty":-18.089549,"marketCap":1831303011},{"date":"2024-04-12","current":-20.928042,"twenty":-29.107626,"median":-22.568955,"eighty":-18.098906,"marketCap":1875571150},{"date":"2024-04-19","current":-18.81184,"twenty":-29.061939,"median":-22.455039,"eighty":-18.224405,"marketCap":1685917123},{"date":"2024-04-26","current":-20.267704,"twenty":-28.863962,"median":-22.311113,"eighty":-18.256547,"marketCap":1816391638},{"date":"2024-05-03","current":-20.281918,"twenty":-28.794162,"median":-22.289169,"eighty":-18.270537,"marketCap":1817665530},{"date":"2024-05-10","current":-20.105056,"twenty":-28.789086,"median":-22.270856,"eighty":-18.288305,"marketCap":1801815151},{"date":"2024-05-17","current":-17.123915,"twenty":-28.636796,"median":-22.232392,"eighty":-18.098906,"marketCap":1672681180},{"date":"2024-05-24","current":-18.288418,"twenty":-28.476893,"median":-22.116999,"eighty":-18.062811,"marketCap":1786430959},{"date":"2024-05-31","current":-16.11295,"twenty":-28.435013,"median":-22.068918,"eighty":-17.902107,"marketCap":1573929112},{"date":"2024-06-07","current":-26.55105,"twenty":-28.381712,"median":-22.102574,"eighty":-17.902107,"marketCap":2593533072},{"date":"2024-06-14","current":-24.646705,"twenty":-28.337752,"median":-22.198735,"eighty":-17.932407,"marketCap":2407514791},{"date":"2024-06-21","current":-22.312809,"twenty":-28.3175,"median":-22.24579,"eighty":-17.974375,"marketCap":2179537500},{"date":"2024-06-28","current":-18.680713,"twenty":-28.3175,"median":-22.24579,"eighty":-18.00318,"marketCap":1824750754},{"date":"2024-07-05","current":-17.874111,"twenty":-28.267548,"median":-22.198735,"eighty":-17.932407,"marketCap":1745961056},{"date":"2024-07-12","current":-20.408464,"twenty":-28.068249,"median":-22.08815,"eighty":-17.932407,"marketCap":1993519219},{"date":"2024-07-15","current":-20.943017,"twenty":-28.006064,"median":-22.078534,"eighty":-17.941595,"marketCap":2045734877},{"date":"2024-08-02","current":-17.387286,"twenty":-27.943879,"median":-22.068918,"eighty":-17.908069,"marketCap":1698407510},{"date":"2024-08-09","current":-16.461364,"twenty":-27.802578,"median":-21.942986,"eighty":-17.823234,"marketCap":1607962532},{"date":"2024-08-16","current":-20.792004,"twenty":-27.780694,"median":-21.876596,"eighty":-17.821691,"marketCap":2088244945},{"date":"2024-08-23","current":-22.295452,"twenty":-27.74971,"median":-21.929398,"eighty":-17.823234,"marketCap":2239243758},{"date":"2024-08-30","current":-21.822777,"twenty":-27.716713,"median":-21.953525,"eighty":-17.863936,"marketCap":2191770646},{"date":"2024-09-06","current":-21.851252,"twenty":-27.691332,"median":-21.926349,"eighty":-17.874111,"marketCap":2194630472},{"date":"2024-09-13","current":-22.944669,"twenty":-27.671026,"median":-21.901472,"eighty":-17.880178,"marketCap":2304447790},{"date":"2024-09-20","current":-22.067657,"twenty":-27.608415,"median":-21.926349,"eighty":-17.902107,"marketCap":2216365150},{"date":"2024-09-27","current":-23.650834,"twenty":-27.565171,"median":-22.001606,"eighty":-17.941595,"marketCap":2375371475},{"date":"2024-10-04","current":-24.083644,"twenty":-27.536769,"median":-22.068918,"eighty":-18.000093,"marketCap":2418840830},{"date":"2024-10-11","current":-22.130301,"twenty":-27.481934,"median":-22.12365,"eighty":-18.029927,"marketCap":2222656767},{"date":"2024-10-18","current":-22.563112,"twenty":-27.163394,"median":-22.116999,"eighty":-18.055104,"marketCap":2266126122},{"date":"2024-10-25","current":-21.333018,"twenty":-26.967956,"median":-22.11226,"eighty":-18.070517,"marketCap":2142581639},{"date":"2024-10-31","current":-21.560813,"twenty":-26.932422,"median":-22.097835,"eighty":-18.080033,"marketCap":2165460247},{"date":"2024-11-08","current":-21.839862,"twenty":-26.875803,"median":-22.107521,"eighty":-18.096607,"marketCap":2193486542},{"date":"2024-11-15","current":-19.500107,"twenty":-26.820843,"median":-22.068288,"eighty":-18.16223,"marketCap":2155736838},{"date":"2024-11-22","current":-15.573182,"twenty":-26.740791,"median":-22.039183,"eighty":-18.047398,"marketCap":1721615252},{"date":"2024-11-29","current":-17.170432,"twenty":-26.702879,"median":-21.932448,"eighty":-17.923218,"marketCap":1898191276},{"date":"2024-12-06","current":-16.181125,"twenty":-26.575564,"median":-21.883856,"eighty":-17.833409,"marketCap":1788823393},{"date":"2024-12-13","current":-16.424567,"twenty":-26.524021,"median":-21.851252,"eighty":-17.817061,"marketCap":1815735909},{"date":"2024-12-20","current":-15.523314,"twenty":-26.386717,"median":-21.835102,"eighty":-17.715324,"marketCap":1716102339},{"date":"2024-12-27","current":-15.30059,"twenty":-26.269962,"median":-21.822777,"eighty":-17.687076,"marketCap":1691480250},{"date":"2025-01-03","current":-14.601342,"twenty":-26.20397,"median":-21.78933,"eighty":-17.625803,"marketCap":1614178343},{"date":"2025-01-10","current":-14.005686,"twenty":-26.17605,"median":-21.782692,"eighty":-17.604018,"marketCap":1548328570},{"date":"2025-01-17","current":-13.974608,"twenty":-26.160821,"median":-21.780436,"eighty":-17.514986,"marketCap":1544892930},{"date":"2025-01-24","current":-14.482211,"twenty":-26.10752,"median":-21.737354,"eighty":-17.469621,"marketCap":1601008389},{"date":"2025-01-31","current":-15.7046,"twenty":-26.035182,"median":-21.700984,"eighty":-17.381485,"marketCap":1736143575},{"date":"2025-02-07","current":-15.549212,"twenty":-26.032644,"median":-21.680405,"eighty":-17.295679,"marketCap":1718965373},{"date":"2025-02-14","current":-12.622728,"twenty":-25.9819,"median":-21.605123,"eighty":-17.234446,"marketCap":1395442576},{"date":"2025-02-21","current":-12.115125,"twenty":-25.903236,"median":-21.581883,"eighty":-17.21037,"marketCap":1339327118},{"date":"2025-02-28","current":-11.819887,"twenty":-25.84482,"median":-21.567582,"eighty":-17.171628,"marketCap":1306688535},{"date":"2025-03-07","current":-11.01217,"twenty":-25.735679,"median":-21.559435,"eighty":-17.124089,"marketCap":1349277189},{"date":"2025-03-14","current":-9.547313,"twenty":-25.689992,"median":-21.491953,"eighty":-17.045645,"marketCap":1169794078},{"date":"2025-03-21","current":-10.235281,"twenty":-25.609403,"median":-21.417887,"eighty":-16.960589,"marketCap":1254088063},{"date":"2025-03-28","current":-9.33203,"twenty":-25.527539,"median":-21.321628,"eighty":-16.93886,"marketCap":1143416369},{"date":"2025-04-04","current":-7.64253,"twenty":-25.480594,"median":-21.202701,"eighty":-16.831205,"marketCap":936408691},{"date":"2025-04-11","current":-7.043483,"twenty":-25.340669,"median":-21.061141,"eighty":-16.666093,"marketCap":863009847},{"date":"2025-04-17","current":-8.672143,"twenty":-25.329214,"median":-21.042579,"eighty":-16.563339,"marketCap":1062562954},{"date":"2025-04-21","current":-10.183801,"twenty":-25.313941,"median":-21.002823,"eighty":-16.512979,"marketCap":1247780350}],"updateTime":1745345105225}}}